Hemorrhage Risk Among Patients With Breast Cancer Receiving Concurrent Direct Oral Anticoagulants With Tamoxifen vs Aromatase Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hemorrhage Risk Among Patients With Breast Cancer Receiving Concurrent Direct Oral Anticoagulants With Tamoxifen vs Aromatase Inhibitors

Published:2022-06-28 Issue:6 Volume:5 Page:e2219128
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Wang Tzu-Fei¹²,Clarke Anna E.²³,Awan Arif A.¹²,Tanuseputro Peter¹²³⁴,Carrier Marc¹²,Sood Manish M.¹²³

Affiliation:

1. Department of Medicine, University of Ottawa at the Ottawa Hospital, Ottawa, Ontario, Canada

2. Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

3. ICES uOttawa, Toronto, Ontario, Canada

4. Bruyère Research Institute, Ottawa, Ontario, Canada

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2793634/wang_2022_oi_220552_1655389167.96141.pdf

Reference44 articles.

1. Venous thromboembolism in cancer patients: a population-based cohort study.;Mulder;Blood,2021

2. Incidence of atrial fibrillation in different major cancer subtypes: a nationwide population-based 12?year follow up study.;Jakobsen;BMC Cancer,2019

3. Anticancer drug-related nonvalvular atrial fibrillation: challenges in management and antithrombotic strategies.;Tufano;Semin Thromb Hemost,2018

4. Malignancies, prothrombotic mutations, and the risk of venous thrombosis.;Blom;JAMA,2005

5. What impact does venous thromboembolism and bleeding have on cancer patients’ quality of life?;Lloyd;Value Health,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prevalence of relevant drug-drug interactions and associated clinical outcomes in patients with cancer-associated thrombosis on concurrent anticoagulation and anticancer or supportive care therapies;Thrombosis Research;2023-11

2. Effect of the P-glycoprotein inhibitor tamoxifen on edoxaban plasma levels in women with breast cancer;Thrombosis Research;2023-08

3. The 5 most frequently asked questions about factor Xa inhibitors;HEMATOL-AM SOC HEMAT;2022

4. The 5 most frequently asked questions about factor Xa inhibitors;Hematology;2022-12-09

5. Bleeding and thrombotic events in atrial fibrillation patients with cancer: a systematic review and meta-analysis;Internal and Emergency Medicine;2022-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3